Citations (116)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (32)
Hiroto Tsuboi, Yuko Kaneko, Kei Ikeda, Toshihiko Aranishi, Zhihong Cai & Tomoko Ishizuka. (2022) Current status of shared decision making for rheumatoid arthritis treatment in Japan: a web-based survey on physicians and patients. Current Medical Research and Opinion 38:5, pages 853-861.
Read now
Read now
Hiroshi Fujimaki, Akihiro Nakazawa, Motoharu Hirano, Tsuyoshi Takeuchi, Ayahiro Kadowaki, Yoshihiro Kusayama, Manabu Ide, Kenzo Kanai, Yoori Kim, Joji Matsubara, Ken Kumagai & Yutaka Inaba. (2021) Status of fracture risk assessment and osteoporosis treatment in Japanese patients with rheumatoid arthritis. Modern Rheumatology 31:5, pages 987-991.
Read now
Read now
Mochihito Suzuki, Toshihisa Kojima, Nobunori Takahashi, Shuji Asai, Kenya Terabe, Atsushi Kaneko, Yuji Hirano, Masahiro Hanabayashi, Takeshi Oguchi, Hideki Takagi, Yasuhide Kanayama, Yuichiro Yabe, Koji Funahashi, Takayoshi Fujibayashi, Seiji Tsuboi, Takayasu Ito, Yutaka Yoshioka, Hisato Ishikawa, Yasumori Sobue, Tsuyoshi Nishiume, Yutaka Yokota & Naoki Ishiguro. (2021) Higher doses of methotrexate associated with discontinuation of oral glucocorticoids after initiation of biological DMARDs: A retrospective observational study based on data from a Japanese multicenter registry study. Modern Rheumatology 31:4, pages 796-802.
Read now
Read now
Eri Nakamura, Takuya Kotani, Yuri Hiramatsu, Kenichiro Hata, Ayaka Yoshikawa, Yoko Matsumura, Nao Tokai, Yumiko Wada, Daisuke Fujita & Tohru Takeuchi. (2021) Simplified disease activity index and clinical disease activity index before and during pregnancy correlate with those at postpartum in patients with rheumatoid arthritis. Modern Rheumatology 31:4, pages 809-816.
Read now
Read now
Tsutomu Takeuchi, Maureen Rischmueller, Ricardo Blanco, Ricardo M Xavier, Yukitaka Ueki, Tatsuya Atsumi, Su Chen, Alan Friedman, Aileen L Pangan, Vibeke Strand & Ronald F van Vollenhoven. (2021) Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY study. Modern Rheumatology 31:3, pages 534-542.
Read now
Read now
Yoshiya Tanaka, Hideto Kameda, Kazuyoshi Saito, Yuko Kaneko, Eiichi Tanaka, Shinsuke Yasuda, Naoto Tamura, Keishi Fujio, Takao Fujii, Toshihisa Kojima, Tatsuhiko Anzai, Chikuma Hamada, Yoshihisa Fujino, Shinya Matsuda & Hitoshi Kohsaka. (2021) Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC study. Modern Rheumatology 31:1, pages 42-52.
Read now
Read now
Masayo Kojima, Takeo Nakayama, Kiichiro Tsutani, Ataru Igarashi, Toshihisa Kojima, Sadao Suzuki, Nobuyuki Miyasaka & Hisashi Yamanaka. (2020) Epidemiological characteristics of rheumatoid arthritis in Japan: Prevalence estimates using a nationwide population-based questionnaire survey. Modern Rheumatology 30:6, pages 941-947.
Read now
Read now
Tomohiro Ishimaru, Yoshihisa Fujino, Tatsuhiko Anzai, Shinya Matsuda & Yoshiya Tanaka. (2020) Validity and responsiveness of the Work Functioning Impairment Scale (WFun) in rheumatoid arthritis patients: A multicenter prospective study . Modern Rheumatology 30:5, pages 821-827.
Read now
Read now
Yoshiya Tanaka, Tsuneyo Mimori, Hisashi Yamanaka, Naomi Sunaga, Kazuo Morita, Junko Kimura & Tsutomu Takeuchi. (2020) Effectiveness, safety, and methotrexate dose-tapering pattern over two years of treatment with adalimumab and ≥12 mg/week methotrexate for early rheumatoid arthritis: Results of the HAWK postmarketing surveillance study in Japan. Modern Rheumatology 30:3, pages 424-433.
Read now
Read now
Tsutomu Takeuchi, Hisashi Yamanaka, Kunihiro Yamaoka, Shoko Arai, Shigeyuki Toyoizumi, Ryan DeMasi, Yuri Fukuma, Tomohiro Hirose, Naonobu Sugiyama, Samuel H. Zwillich & Yoshiya Tanaka. (2019) Efficacy and safety of tofacitinib in Japanese patients with rheumatoid arthritis by background methotrexate dose: A post hoc analysis of clinical trial data. Modern Rheumatology 29:5, pages 756-766.
Read now
Read now
Shoko Kasai, Ryoko Sakai, Ryuji Koike, Hitoshi Kohsaka, Nobuyuki Miyasaka & Masayoshi Harigai. (2019) Higher risk of hospitalized infection, cardiovascular disease, and fracture in patients with rheumatoid arthritis determined using the Japanese health insurance database. Modern Rheumatology 29:5, pages 788-794.
Read now
Read now
Hisashi Yamanaka, Tomohiro Hirose, Yutaka Endo, Noriko Sugiyama, Yuri Fukuma, Yosuke Morishima, Naonobu Sugiyama, Noritoshi Yoshii, Nobuyuki Miyasaka & Takao Koike. (2019) Three-year safety and two-year effectiveness of etanercept in patients with rheumatoid arthritis in Japan: Results of long-term postmarketing surveillance. Modern Rheumatology 29:5, pages 737-746.
Read now
Read now
Yoshiya Tanaka, Tsuneyo Mimori, Hisashi Yamanaka, Ryo Nakajima, Kazuo Morita, Junko Kimura & Tsutomu Takeuchi. (2019) Effectiveness and safety of initiating adalimumab plus ≥12 mg/week methotrexate with adjustable dosing in biologic-naïve patients with early rheumatoid arthritis: HAWK study postmarketing surveillance in Japan. Modern Rheumatology 29:4, pages 572-580.
Read now
Read now
Yuko Kaneko, Tsutomu Takeuchi, Zhihong Cai, Masayo Sato, Kenta Awakura, Carol Gaich, Baojin Zhu, Jiaying Guo & Yoshiya Tanaka. (2018) Determinants of Patient’s Global Assessment of Disease Activity and Physician’s Global Assessment of Disease Activity in patients with rheumatoid arthritis: A post hoc analysis of overall and Japanese results from phase 3 clinical trials. Modern Rheumatology 28:6, pages 960-967.
Read now
Read now
Naoki Ishiguro, Maxime Dougados, Zhihong Cai, Baojin Zhu, Masato Ishida, Masayo Sato, Carol Gaich, Amanda Quebe, Ivaylo Stoykov & Yoshiya Tanaka. (2018) Relationship between disease activity and patient-reported outcomes in rheumatoid arthritis: Post hoc analyses of overall and Japanese results from two phase 3 clinical trials. Modern Rheumatology 28:6, pages 950-959.
Read now
Read now
Tsutomu Takeuchi, Masayoshi Harigai, Yoshiya Tanaka, Hisashi Yamanaka, Naoki Ishiguro, Kazuhiko Yamamoto, Nobuyuki Miyasaka, Takao Koike, Yoshifumi Ukyo, Yutaka Ishii, Toru Yoshinari & Daniel Baker. (2018) Clinical efficacy, radiographic, and safety results of golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior therapy with disease-modifying antirheumatic drugs: Final results of the GO-MONO trial through week 120. Modern Rheumatology 28:5, pages 770-779.
Read now
Read now
Rosarin Sruamsiri, Jörg Mahlich, Eiichi Tanaka & Hisashi Yamanaka. (2018) Productivity loss of Japanese patients with rheumatoid arthritis – A cross-sectional survey. Modern Rheumatology 28:3, pages 482-489.
Read now
Read now
Yoshiya Tanaka, Kiyotaka Yamazaki, Ryo Nakajima, Shuichi Komatsu, Ataru Igarashi, Toshiro Tango & Tsutomu Takeuchi. (2018) Economic impact of adalimumab treatment in Japanese patients with rheumatoid arthritis from the adalimumab non-interventional trial for up-verified effects and utility (ANOUVEAU) study. Modern Rheumatology 28:1, pages 39-47.
Read now
Read now
Mie Fusama, Hideko Nakahara, Yvonne van Eijk-Hustings, Susan Oliver & Tsutomu Takeuchi. (2017) Survey on attitudes regarding EULAR recommendations for the role of nurses involved in medical care of patients with chronic inflammatory arthritis in Japan. Modern Rheumatology 27:5, pages 886-893.
Read now
Read now
Takashi Kaito, Shirou Ohshima, Hiroyasu Fujiwara, Takahiro Makino, Kazuo Yonenobu & Hideki Yoshikawa. (2017) Incidence and risk factors for cervical lesions in patients with rheumatoid arthritis under the current pharmacologic treatment paradigm. Modern Rheumatology 27:4, pages 593-597.
Read now
Read now
Yasmin Moustafa Ahmed, Basim Anwar Shehata Messiha & Ali Ahmed Abo-Saif. (2017) Granisetron and carvedilol can protect experimental rats againstadjuvant-induced arthritis. Immunopharmacology and Immunotoxicology 39:2, pages 97-104.
Read now
Read now
Erika Matsubara, Noritada Yoshikawa, Osamu Hosono, Hiroyuki Baba, Toshiki Eri, Masaaki Uehara, Aya Oda, Chieko Sekita, Atsuo Taniguchi & Hirotoshi Tanaka. (2017) A rheumatoid arthritis patient complicated with adenine phosphoribosyltransferase deficiency and unilateral renal agenesis: a first case report. Modern Rheumatology Case Reports 1:1, pages 15-19.
Read now
Read now
Joerg Mahlich & Rosarin Sruamsiri. (2017) Treatment patterns of rheumatoid arthritis in Japanese hospitals and predictors of the initiation of biologic agents. Current Medical Research and Opinion 33:1, pages 101-107.
Read now
Read now
Jörg Mahlich & Rosarin Sruamsiri. (2016) Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan. Patient Preference and Adherence 10, pages 1509-1519.
Read now
Read now
Masayoshi Harigai, Naoki Ishiguro, Shigeko Inokuma, Tsuneyo Mimori, Junnosuke Ryu, Syuji Takei, Tsutomu Takeuchi, Yoshiya Tanaka, Yoshinari Takasaki, Hisashi Yamanaka, Masahiko Watanabe, Hiroshi Tamada & Takao Koike. (2016) Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis. Modern Rheumatology 26:4, pages 491-498.
Read now
Read now
Yoshiya Tanaka, Masayoshi Harigai, Tsutomu Takeuchi, Hisashi Yamanaka, Naoki Ishiguro, Kazuhiko Yamamoto, Nobuyuki Miyasaka, Takao Koike, Daniel Baker, Yutaka Ishii & Toru Yoshinari. (2016) Clinical efficacy, radiographic progression, and safety through 156 weeks of therapy with subcutaneous golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis despite prior methotrexate therapy: final results of the randomized GO-FORTH trial. Modern Rheumatology 26:4, pages 481-490.
Read now
Read now
Ryoko Sakai, Fumio Hirano, Mari Kihara, Waka Yokoyama, Hayato Yamazaki, Sayoko Harada, Toshihiro Nanki, Ryuji Koike, Nobuyuki Miyasaka & Masayoshi Harigai. (2016) High prevalence of cardiovascular comorbidities in patients with rheumatoid arthritis from a population-based cross-sectional study of a Japanese health insurance database. Modern Rheumatology 26:4, pages 522-528.
Read now
Read now
Yusuke Sugimura, Naohisa Miyakoshi, Seiya Miyamoto, Yuji Kasukawa, Michio Hongo & Yoichi Shimada. (2016) Prevalence of and factors associated with lumbar spondylolisthesis in patients with rheumatoid arthritis. Modern Rheumatology 26:3, pages 342-346.
Read now
Read now
Shintaro Hirata, Nadine Defranoux, Kentaro Hanami, Kunihiro Yamaoka & Yoshiya Tanaka. (2015) A multi-biomarker disease activity score for monitoring rheumatoid arthritis. Current Biomarker Findings 5, pages 69-78.
Read now
Read now
Tomonori Kobayakawa, Toshihisa Kojima, Nobunori Takahashi, Masatoshi Hayashi, Yuichiro Yabe, Atsushi Kaneko, Tomone Shioura, Kiwamu Saito, Yuji Hirano, Yasuhide Kanayama, Hiroyuki Miyake, Nobuyuki Asai, Koji Funahashi, Shinya Hirabara, Masahiro Hanabayashi, Shuji Asai & Naoki Ishiguro. (2015) Drug retention rates of second biologic agents after switching from tumor necrosis factor inhibitors for rheumatoid arthritis in Japanese patients on low-dose methotrexate or without methotrexate. Modern Rheumatology 25:2, pages 251-256.
Read now
Read now
Tsutomu Takeuchi, Nobuyuki Miyasaka, Shinichi Kawai, Naonobu Sugiyama, Hirotoshi Yuasa, Noriaki Yamashita, Noriko Sugiyama, Lorin Craig Wagerle, Bonnie Vlahos & Joseph Wajdula. (2015) Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials. Modern Rheumatology 25:2, pages 173-186.
Read now
Read now
Tsutomu Takeuchi, Yoshiya Tanaka, David Close, Alex Godwood, Chi-Yuan Wu & Didier Saurigny. (2015) Efficacy and safety of mavrilimumab in Japanese subjects with rheumatoid arthritis: Findings from a Phase IIa study. Modern Rheumatology 25:1, pages 21-30.
Read now
Read now
Articles from other publishers (84)
Shigeki Momohara, Kei Ikeda, Masahiro Tada, Toshiaki Miyamoto, Takanori Mito, Keita Fujimoto, Ayako Shoji, Eriko Wakita & Mitsumasa Kishimoto. (2023) Patient–Physician Communication and Perception of Treatment Goals in Rheumatoid Arthritis: An Online Survey of Patients and Physicians. Rheumatology and Therapy 10:4, pages 917-931.
Crossref
Crossref
Daye Diana Choi, Kyung-Ah Kim, Kyung-Ah Park & Sei Yeul Oh. (2023) Pregnancy prevalence and outcomes after optic neuritis in South Korea. Scientific Reports 13:1.
Crossref
Crossref
Yoshiya Tanaka, Tsukasa Matsubara, Tatsuya Atsumi, Koichi Amano, Naoki Ishiguro, Eiji Sugiyama, Kunihiro Yamaoka, Bernard G Combe, Alan J Kivitz, Sang-Cheol Bae, Edward C Keystone, Peter Nash, Mark Genovese, Franziska Matzkies, Beatrix Bartok, Alena Pechonkina, Akira Kondo, Lei Ye, Qi Gong, Chantal Tasset & Tsutomu Takeuchi. (2023) Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results. Modern Rheumatology 33:4, pages 668-679.
Crossref
Crossref
Tatsuya Atsumi, Yoshiya Tanaka, Tsukasa Matsubara, Koichi Amano, Naoki Ishiguro, Eiji Sugiyama, Kunihiro Yamaoka, René Westhovens, Daniel W T Ching, Osvaldo Daniel Messina, Gerd R Burmester, Mark Genovese, Beatrix Bartok, Alena Pechonkina, Akira Kondo, Zhaoyu Yin, Qi Gong, Chantal Tasset & Tsutomu Takeuchi. (2023) Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3). Modern Rheumatology 33:4, pages 657-667.
Crossref
Crossref
Noboru Kitamura, Hitomi Kobayashi, Yosuke Nagasawa, Kaita Sugiyama, Hiroshi Tsuzuki, Yutaka Tanikawa, Natsumi Ikumi, Yuito Okada, Yasuo Takahashi, Satoshi Asai, Naoto Tamura, Michihiro Ogasawara, Toshio Kawamoto, Ryohei Kuwatsuru, Hiromichi Tamaki, Genki Kidoguchi, Mutsuto Tateishi, Makiko Kimura, Yuichi Mochida, Kengo Harigane, Takayuki Shimazaki, Takao Koike, Kazuhide Tanimura, Hiroshi Kataoka, Koichi Amano, Hidekata Yasuoka & Masami Takei. (2023) Risk factors associated with relapse after methotrexate dose reduction in patients with rheumatoid arthritis receiving golimumab and methotrexate combination therapy. International Journal of Rheumatic Diseases.
Crossref
Crossref
Masayoshi Harigai, Takao Fujii, Ryoko Sakai, Ataru Igarashi, Ayako Shoji, Hiroko Yamaguchi, Katsuhiko Iwasaki, Misako Makishima, Amika Yoshida, Norihiro Okada, Katsuhisa Yamashita & Yutaka Kawahito. (2023) Risk of hospitalized infections in older elderly patients with rheumatoid arthritis treated with tocilizumab or other biological/targeted synthetic disease-modifying antirheumatic drugs: Evaluation of data from a Japanese claims database. Modern Rheumatology.
Crossref
Crossref
Masataka Kuwana, Naoto Tamura, Shinsuke Yasuda, Keishi Fujio, Ayako Shoji, Hiroko Yamaguchi, Katsuhiko Iwasaki, Misako Makishima, Yuichi Kawata, Katsuhisa Yamashita & Ataru Igarashi. (2023) Cost-effectiveness analyses of biologic and targeted synthetic disease-modifying anti-rheumatic diseases in patients with rheumatoid arthritis: Three approaches with a cohort simulation and real-world data. Modern Rheumatology 33:2, pages 302-311.
Crossref
Crossref
Yoshifumi Ohashi, Nobunori Takahashi, Yasumori Sobue, Mochihito Suzuki, Kyosuke Hattori, Kenji Kishimoto, Kenya Terabe, Shuji Asai, Toshihisa Kojima, Masayo Kojima & Shiro Imagama. (2023) Factors associated with frailty in rheumatoid arthritis patients with decreased renal function. Modern Rheumatology 33:2, pages 323-329.
Crossref
Crossref
Kazuto Togitani, Fumiya Ogasawara, Yu Arakawa, Natsuki Sugimura, Ryohei Miyazaki & Kensuke Kojima. (2023) Psoas and Mediastinal Abscesses during Intravenous Tocilizumab Treatment in Multicentric Castleman Disease. Internal Medicine 62:3, pages 449-452.
Crossref
Crossref
Hisaaki Isaji & Kiyofumi Yamada. (2022) A Survey on the Actual Use of and Reasons for Heated Tobacco Products in Patients with Rheumatoid Arthritis. International Journal of Environmental Research and Public Health 19:19, pages 12465.
Crossref
Crossref
Ryoko Sakai, Eiichi Tanaka, Eisuke Inoue, Minako Sato, Masaru Tanaka, Katsunori Ikari, Hisashi Yamanaka & Masayoshi Harigai. (2022) Association between patient-reported outcomes and impairments in work and activity in patients with rheumatoid arthritis in clinical remission: A retrospective analysis using the IORRA database. Modern Rheumatology.
Crossref
Crossref
Ji-Hoon Baek, Su Chan Lee, Jin-Woo Kim, Hye Sun Ahn & Chang Hyun Nam. (2021) Inferior outcomes of primary total knee arthroplasty in patients with rheumatoid arthritis compared to patients with osteoarthritis. Knee Surgery, Sports Traumatology, Arthroscopy 30:8, pages 2786-2792.
Crossref
Crossref
Takaaki Nagase, Yuya Takakubo, Yuki Yokoyama, Saeko Nagase, Suran Yang, Ryusuke Honma, Hiroharu Oki, Juji Ito, Akiko Sasaki & Michiaki Takagi. (2022) Progression of Bone and Joint Destruction During the Perinatal Period in Patients With Rheumatoid Arthritis and Juvenile Idiopathic Arthritis in the Last Decade. Cureus.
Crossref
Crossref
Yoshiya Tanaka, Tsukasa Matsubara, Koichi Hashizume, Norihito Amano & Tsutomu Takeuchi. (2022)
Efficacy and safety of abatacept in biologic-naïve patients with active rheumatoid arthritis by background methotrexate dose:
post hoc
analysis of a randomized, placebo-controlled, phase 4 study
. Modern Rheumatology 32:3, pages 500-507.
Crossref
Crossref
Mikiko SHIMIZU, Eisuke MIZUTANI, Tsuyoshi SHIGA & Masayuki HASHIGUCHI. (2022) Comparison of Clinical Equivalence of Infliximab and its Biosimilar Combinations with Methotrexate in the Treatment of Rheumatoid Arthritis. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 53:2, pages 15-24.
Crossref
Crossref
Kazuhiro Maeda, Ken Yoshida, Tetsuro Nishizawa, Kazuhiro Otani, Yu Yamashita, Hinako Okabe, Yuka Hadano, Tomohiro Kayama, Daitaro Kurosaka & Mitsuru Saito. (2022) Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments. International Journal of Molecular Sciences 23:5, pages 2871.
Crossref
Crossref
Tomohiro Hirose, Isao Kawaguchi, Tatsunori Murata & Tatsuya Atsumi. (2022) Cost-Effectiveness Analysis of Etanercept 25 mg Maintenance Therapy After Treatment With Etanercept 50 mg for Moderate Rheumatoid Arthritis in the PRESERVE Trial in Japan. Value in Health Regional Issues 28, pages 105-111.
Crossref
Crossref
Kohei Nakatsu, Rashedur Rahman, Kento Morita, Daisuke Fujita & Syoji Kobashi. (2022) Automatic Carpal Site Detection Method for Evaluation of Rheumatoid Arthritis Using Deep Learning. Journal of Advanced Computational Intelligence and Intelligent Informatics 26:1, pages 42-50.
Crossref
Crossref
Miwa Hamasaki, Tomoki Origuchi & Emi Matsuura. (2022) Factors associated with depressive symptoms in Japanese women with rheumatoid arthritis. Rheumatology Advances in Practice 6:1.
Crossref
Crossref
Kiyoshi Kubota, Masaki Yoshizawa, Satoru Takahashi, Yoshiaki Fujimura, Hiroko Nomura & Hitoshi Kohsaka. (2021) The validity of the claims-based definition of rheumatoid arthritis evaluated in 64 hospitals in Japan. BMC Musculoskeletal Disorders 22:1.
Crossref
Crossref
Yutaka Kawahito, Yuya Takakubo, Akio Morinobu, Naoko Matsubara, Orsolya Nagy & Eiji Sugiyama. (2021) Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE). PLOS ONE 16:11, pages e0259389.
Crossref
Crossref
Miho Mori, Rie Tobita, Chizu Egusa, Tatsuo Maeda, Namiko Abe, Hiroshi Kawakami, Kenichiro Mae, Yuka Matsumoto, Yasuhiro Kawachi & Yukari Okubo. (2021) Clinical background of patients with psoriasiform skin lesions due to tumor necrosis factor antagonist administration at a single center. The Journal of Dermatology 48:11, pages 1745-1753.
Crossref
Crossref
Atsushi Hirata, Ryosuke Ota, Takeo Hata, Takeshi Hamada, Masami Nishihara, Kazuhisa Uchiyama & Takahiro Katsumata. (2021) Prescribing Trends of Biologic Disease-Modifying Anti-rheumatic Drugs Using a Claims Database from 6 Million People in Japan. Clinical Drug Investigation 41:11, pages 967-974.
Crossref
Crossref
Shigeki Ito, Masako Iwanaga, Kisato Nosaka, Yoshitaka Imaizumi, Kenji Ishitsuka, Masahiro Amano, Atae Utsunomiya, Yoshiki Tokura, Toshiki Watanabe, Kaoru Uchimaru & Kunihiro Tsukasaki. (2021) Epidemiology of adult T‐cell leukemia‐lymphoma in Japan: An updated analysis, 2012‐2013. Cancer Science 112:10, pages 4346-4354.
Crossref
Crossref
Hiroko Hashimoto, Shimpei Hashimoto & Yoshihiro Shimazaki. (2021) Association Between the Extent of Periodontal Inflammation and the Severity of Rheumatoid Arthritis in Japanese Patients With Rheumatoid Arthritis. International Dental Journal 71:5, pages 429-437.
Crossref
Crossref
Susumu Yamaguchi, Nobutaka Horie, Shuntaro Sato, Makio Kaminogo, Yoichi Morofuji, Tsuyoshi Izumo, Takeo Anda, Kazuhiko Suyama & Takayuki Matsuo. (2020) Characteristics of aneurysmal subarachnoid hemorrhage associated with rheumatic disease. Neurosurgical Review 44:5, pages 2611-2618.
Crossref
Crossref
Yusuke Okada, Ryota Sakai, Marie Sato-Fitoussi, Marika Nodera, Shoichi Yoshinaga, Akiko Shibata, Takahiko Kurasawa, Tsuneo Kondo & Koichi Amano. (2021) Potential Triggers for Thrombocytopenia and/or Hemorrhage by the BNT162b2 Vaccine, Pfizer-BioNTech. Frontiers in Medicine 8.
Crossref
Crossref
Akihiko Umazume, Nobuyuki Ohguro, Annabelle A. Okada, Kenichi Namba, Koh-Hei Sonoda, Hidekazu Tsuruga, Kazuo Morita & Hiroshi Goto. (2021) Prevalence and incidence rates and treatment patterns of non-infectious uveitis in Japan: real-world data using a claims database. Japanese Journal of Ophthalmology 65:5, pages 657-665.
Crossref
Crossref
Nobuhiko Nakamura, Masaaki Kusumoto & Yoshitaka Yano. (2021) Optimal vial sizes for infliximab injection: a simulation study of Japanese demographic data. International Journal of Pharmacy Practice 29:4, pages 344-349.
Crossref
Crossref
Ko-Jen Li, Chia-Li Chang, Chih-Yi Hsin & Chao-Hsiun Tang. (2021) Switching and Discontinuation Pattern of Biologic Disease-Modifying Antirheumatic Drugs and Tofacitinib for Patients With Rheumatoid Arthritis in Taiwan. Frontiers in Pharmacology 12.
Crossref
Crossref
Yusuke Karasawa, Isao Kamae, Kazutaka Nozawa, Shigeki Zeniya, Tatsunori Murata, Satoshi Soen & Choitsu Sakamoto. (2021) Cost-effectiveness analysis of branded and authorized generic celecoxib for patients with chronic pain in Japan. PLOS ONE 16:7, pages e0253547.
Crossref
Crossref
Chiaki Hosoda, Takashi Ishiguro, Ryuji Uozumi, Miyuki Ueda, Naomi Takata & Noboru Takayanagi. (2021) Characteristics of pulmonary cryptococcosis in patients with rheumatoid arthritis. BMJ Open Respiratory Research 8:1, pages e000805.
Crossref
Crossref
Kenichi Arai, Chisato Miura, Shin-Ya Kawashiri, Tetsuo Imai & Toru Kobayashi. (2021) Diagnostic Imaging Support System for Rheumatoid Arthritis Using Ultrasound Images. Diagnostic Imaging Support System for Rheumatoid Arthritis Using Ultrasound Images.
Takahiro Okada, Noriko Kohyama, Miki Takenaka, Takashi Yamaguchi, Tatsuya Kurihara, Kosuke Sakurai, Yusuke Miwa & Mari Kogo. (2021) Scoring Model to Predict a Low Disease Activity in Elderly Rheumatoid Arthritis Patients Initially Treated with Biological Disease-modifying Antirheumatic Drugs. Internal Medicine 60:12, pages 1827-1834.
Crossref
Crossref
Philip G. Conaghan, Eduardo Mysler, Yoshiya Tanaka, Barbara Da Silva-Tillmann, Tim Shaw, John Liu, Ryan Ferguson, Jeffrey V. Enejosa, Stanley Cohen, Peter Nash, William Rigby & Gerd Burmester. (2021) Upadacitinib in Rheumatoid Arthritis: A Benefit–Risk Assessment Across a Phase III Program. Drug Safety 44:5, pages 515-530.
Crossref
Crossref
Edith L. Graham, Jeffrey R. Clark, Zachary S. Orban, Patrick H. Lim, April L. Szymanski, Carolyn Taylor, Rebecca M. DiBiase, Dan Tong Jia, Roumen Balabanov, Sam U. Ho, Ayush Batra, Eric M. Liotta & Igor J. Koralnik. (2021) Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”. Annals of Clinical and Translational Neurology 8:5, pages 1073-1085.
Crossref
Crossref
Yoshitake Kitanishi, Masakazu Fujiwara & Bruce Binkowitz. (2021) Patient journey through cases of depression from claims database using machine learning algorithms. PLOS ONE 16:2, pages e0247059.
Crossref
Crossref
José J. Hernández-Muñoz, Wenfei Wei & Radames Sierra-Zorita. (2021) Prevalence of Rheumatoid Arthritis and Drug Dispensing Patterns Among Medicaid and Medicaid–Medicare Dually Eligible Beneficiaries in Puerto Rico. Arthritis Care & Research 73:2, pages 199-206.
Crossref
Crossref
Ayumi Hida, Misa Imaizumi, Benjamin French, Waka Ohishi, Daisuke Haruta, Katsumi Eguchi, Hideki Nakamura & Atsushi Kawakami. (2021) Association of human T-cell leukemia virus type 1 with prevalent rheumatoid arthritis among atomic bomb survivors. Medicine 100:24, pages e26297.
Crossref
Crossref
Ayako Nakajima, Ryoko Sakai, Eisuke Inoue & Masayoshi Harigai. (2020) Prevalence of patients with rheumatoid arthritis and age‐stratified trends in clinical characteristics and treatment, based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan. International Journal of Rheumatic Diseases 23:12, pages 1676-1684.
Crossref
Crossref
Fumiko Yamairi, Toshiro Yano, Takashi Goto & Tomohisa Iwasaki. (2020) Dose Adjustment of Methotrexate Administered Concomitantly with Golimumab for Rheumatoid Arthritis in Japanese Real-World Clinical Settings. Rheumatology and Therapy 7:4, pages 811-824.
Crossref
Crossref
Isao Matsushita. (2020) Epidemiology, Diagnosis and Practice Guidelines for Rheumatoid Arthritis関節リウマチの疫学・診断・診療ガイドライン. The Japanese Journal of Rehabilitation Medicine 57:11, pages 1005-1010.
Crossref
Crossref
Hyoungyoung Kim, Soo-Kyung Cho, Jin Wook Kim, Sun-Young Jung, Eun Jin Jang, Sang-Cheol Bae, Dae Hyun Yoo & Yoon-Kyoung Sung. (2020) An increased disease burden of autoimmune inflammatory rheumatic diseases in Korea. Seminars in Arthritis and Rheumatism 50:3, pages 526-533.
Crossref
Crossref
Hirohito Shimizu, Hisanori Kobayashi, Masayoshi Kanbori & Yutaka Ishii. (2020) Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data. Rheumatology and Therapy 7:2, pages 311-325.
Crossref
Crossref
Walid Fakhouri, Xiaofei Wang, Immaculate de la Torre & Claudia Nicolay. (2020) A Network Meta-Analysis to Compare Effectiveness of Baricitinib and Other Treatments in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate. Journal of Health Economics and Outcomes Research, pages 10-23.
Crossref
Crossref
Yuzo Ikari, Nobuyuki Yajima & Yusuke Miwa. (2020) The association between age and adverse events due to biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. Medicine 99:52, pages e23861.
Crossref
Crossref
Shuntaro Tsutsumi, Tomoo Sato, Naoko Yagishita, Junji Yamauchi, Natsumi Araya, Daisuke Hasegawa, Misako Nagasaka, Ariella L. G. Coler-Reilly, Eisuke Inoue, Ayako Takata & Yoshihisa Yamano. (2019) Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan. Orphanet Journal of Rare Diseases 14:1.
Crossref
Crossref
Jörg Mahlich & Rosarin Sruamsiri. (2019) Co-insurance and health care utilization in Japanese patients with rheumatoid arthritis: a discontinuity regression approach. International Journal for Equity in Health 18:1.
Crossref
Crossref
Kenji Oku & Tatsuya Atsumi. (2019) Rheumatology practice in Japan: challenges and opportunities. Rheumatology International 39:9, pages 1499-1505.
Crossref
Crossref
Kohta Yamada, Kei Tomihara, Manabu Yamazaki & Makoto Noguchi. (2019) Severe stomatitis caused by misuse of methotrexate in an elderly patient with chronic rheumatoid arthritis. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 31:4, pages 284-287.
Crossref
Crossref
Akinori Maruo, Satoru Esumi, Yoshihisa Kitamura & Toshiaki Sendo. (2019) Drug interaction（44. Combination with molecular target drugs in rheumatoid arthritis）薬物相互作用（44―関節リウマチの分子標的治療薬）. Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 131:1, pages 47-50.
Crossref
Crossref
Zhuoya Zhang, Wei Deng, Qizhe Wu & Lingyun Sun. (2019) Tuberculosis, hepatitis B and herpes zoster in tofacitinib-treated patients with rheumatoid arthritis. Immunotherapy 11:4, pages 321-333.
Crossref
Crossref
Naoya Kikuchi, Masafumi Uesugi, Masao Koda, Tomoaki Shimizu, Kohei Murakami, Mamoru Kono, Haruka Tanaka & Masashi Yamazaki. (2018) Methotrexate-related lymphoproliferative disorder of the lumbar spine origin presenting with severe low-back pain: case report. Journal of Neurosurgery: Spine 29:5, pages 545-548.
Crossref
Crossref
Rosarin Sruamsiri, Hideto Kameda & Jörg Mahlich. (2018) Persistence with Biological Disease-modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs. Drugs - Real World Outcomes 5:3, pages 169-179.
Crossref
Crossref
Hiroko Hashimoto, Shimpei Hashimoto, Akinori Muto, Nanae Dewake & Yoshihiro Shimazaki. (2018) Influence of plaque control on the relationship between rheumatoid arthritis and periodontal health status among Japanese rheumatoid arthritis patients. Journal of Periodontology 89:9, pages 1033-1042.
Crossref
Crossref
Joaquim Carreras, Yara Yukie Kikuti, Masashi Miyaoka, Shinichiro Hiraiwa, Sakura Tomita, Haruka Ikoma, Yusuke Kondo, Sawako Shiraiwa, Kiyoshi Ando, Shinji Sato, Yasuo Suzuki, Ikuo Miura, Giovanna Roncador & Naoya Nakamura. (2018) Genomic Profile and Pathologic Features of Diffuse Large B-Cell Lymphoma Subtype of Methotrexate-associated Lymphoproliferative Disorder in Rheumatoid Arthritis Patients. American Journal of Surgical Pathology 42:7, pages 936-950.
Crossref
Crossref
Masateru Okazaki, Hisanori Kobayashi, Hirohito Shimizu, Yutaka Ishii, Tsutomu Yajima & Masayoshi Kanbori. (2018) Safety, Effectiveness, and Treatment Persistence of Golimumab in Elderly Patients with Rheumatoid Arthritis in Real-World Clinical Practice in Japan. Rheumatology and Therapy 5:1, pages 135-148.
Crossref
Crossref
Florent Guelfucci, Yuko Kaneko, Jörg Mahlich & Rosarin Sruamsiri. (2018) Cost of Depression in Japanese Patients with Rheumatoid Arthritis: Evidence from Administrative Data. Rheumatology and Therapy 5:1, pages 171-183.
Crossref
Crossref
Masateru Okazaki, Hisanori Kobayashi, Yutaka Ishii, Masayoshi Kanbori & Tsutomu Yajima. (2018) Real-World Treatment Patterns for Golimumab and Concomitant Medications in Japanese Rheumatoid Arthritis Patients. Rheumatology and Therapy 5:1, pages 185-201.
Crossref
Crossref
Yuichi Watanabe & Yoshinori Nakata. (2018) Association between outpatient orthopedic surgery costs and healthcare facility characteristics. International Journal of Health Care Quality Assurance 31:3, pages 265-272.
Crossref
Crossref
Soyoung Won, Soo-Kyung Cho, Dam Kim, Minkyung Han, Jiyoung Lee, Eun Jin Jang, Yoon-Kyoung Sung & Sang-Cheol Bae. (2018) Update on the prevalence and incidence of rheumatoid arthritis in Korea and an analysis of medical care and drug utilization. Rheumatology International 38:4, pages 649-656.
Crossref
Crossref
Carolyn Jean Chua-Aguilera, Burkhard Möller & Nikhil Yawalkar. (2017) Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides. Clinical Reviews in Allergy & Immunology 53:3, pages 371-393.
Crossref
Crossref
Jun Tomio, Hayato Yamana, Hiroki Matsui, Hiroyuki Yamashita, Takashi Yoshiyama & Hideo Yasunaga. (2017) Tuberculosis screening prior to anti‐tumor necrosis factor therapy among patients with immune‐mediated inflammatory diseases in Japan: a longitudinal study using a large‐scale health insurance claims database. International Journal of Rheumatic Diseases 20:11, pages 1674-1683.
Crossref
Crossref
Emeline Minichiello, Luca Semerano & Marie-Christophe Boissier. (2017) Incidence, prévalence et sévérité de la polyarthrite rhumatoïde au XXIe siècle. Revue du Rhumatisme Monographies 84:4, pages 303-310.
Crossref
Crossref
Yoshinori Nakata, Tatsuya Yoshimura, Yuichi Watanabe, Hiroshi Otake, Giichiro Oiso & Tomohiro Sawa. (2017) Efficiency of inpatient orthopedic surgery in Japan: a medical claims database analysis. International Journal of Health Care Quality Assurance 30:6, pages 506-515.
Crossref
Crossref
Manjari Lahiri, Amelia Santosa, Lay Kheng Teoh, Jane A. Clayton, Sheen Yee Lim, Gim Gee Teng & Peter P. M. Cheung. (2017) Use of complementary and alternative medicines is associated with delay to initiation of disease‐modifying anti‐rheumatic drug therapy in early inflammatory arthritis. International Journal of Rheumatic Diseases 20:5, pages 567-575.
Crossref
Crossref
Ann Chuo Tang, Hyunchung Kim, Bruce Crawford, Taeko Ishii & Tamas Treuer. (2017) The Use of patient Reported Outcome Measures for Rheumatoid Arthritis in Japan: A Systematic Literature Review. The Open Rheumatology Journal 11:1, pages 43-52.
Crossref
Crossref
Tsutomu Takeuchi, Ryo Nakajima, Shuichi Komatsu, Kiyotaka Yamazaki, Tomohiro Nakamura, Naoki Agata, Ataru Igarashi, Toshiro Tango & Yoshiya Tanaka. (2017) Impact of Adalimumab on Work Productivity and Activity Impairment in Japanese Patients with Rheumatoid Arthritis: Large-Scale, Prospective, Single-Cohort ANOUVEAU Study. Advances in Therapy 34:3, pages 686-702.
Crossref
Crossref
N. Al-Shorbaji, E. M. Borycki, M. Kimura, C. U. Lehmann, N. M. Lorenzi, L. A. Moura & A. Winter. (2017) Discussion of “Representation of People’s Decisions in Health Information Systems: A Complementary Approach for Understanding Health Care Systems and Population Health”. Methods of Information in Medicine 56:Open, pages e20-e29.
Crossref
Crossref
Takumi Matsumoto, Izumi Nakada, Takuo Juji, Ichiro Nakamura & Katsumi Ito. (2016) Radiologic Patterning of Hallux Deformity in Rheumatoid Arthritis and Its Relationship to Flatfoot. The Journal of Foot and Ankle Surgery 55:5, pages 948-954.
Crossref
Crossref
Kaname Yoshizawa, Satoru Joshita, Akihiro Matsumoto, Takeji Umemura, Eiji Tanaka, Susumu Morita, Toshitaka Maejima & Masao Ota. (2016) Incidence and prevalence of autoimmune hepatitis in the Ueda area, Japan. Hepatology Research 46:9, pages 878-883.
Crossref
Crossref
Naonobu Sugiyama, Yutaka Kawahito, Takao Fujii, Tatsuya Atsumi, Tatsunori Murata, Yosuke Morishima & Yuri Fukuma. (2016) Treatment Patterns, Direct Cost of Biologics, and Direct Medical Costs for Rheumatoid Arthritis Patients: A Real-world Analysis of Nationwide Japanese Claims Data. Clinical Therapeutics 38:6, pages 1359-1375.e1.
Crossref
Crossref
Alla Ishchenko & Rik J. Lories. (2016) Safety and Efficacy of Biological Disease-Modifying Antirheumatic Drugs in Older Rheumatoid Arthritis Patients: Staying the Distance. Drugs & Aging 33:6, pages 387-398.
Crossref
Crossref
Nibah Fatimah, Babur Salim, Amjad Nasim, Kamran Hussain, Harris Gul & Sarah Niazi. (2016) Frequency of methotrexate intolerance in rheumatoid arthritis patients using methotrexate intolerance severity score (MISS questionnaire). Clinical Rheumatology 35:5, pages 1341-1345.
Crossref
Crossref
Kensuke Ochi, Takefumi Furuya, Mina Ishibashi, Makiko Watanabe, Katsunori Ikari, Atsuo Taniguchi, Hisashi Yamanaka & Shigeki Momohara. (2015) Risk factors associated with the occurrence of proximal humerus fractures in patients with rheumatoid arthritis: a custom strategy for preventing proximal humerus fractures. Rheumatology International 36:2, pages 213-219.
Crossref
Crossref
Hotaka Maruyama, Shinji Miyake & Tatsuo Kurokawa. (2016) Does Use of a Biosimilar Product Reduce the Expenditure of Patients?. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 42:7, pages 499-511.
Crossref
Crossref
Jorge Augusto Díaz-Rojas, Fabián Antonio Dávila-Ramírez, Gerardo Quintana-López, Fabio Aristizábal-Gutiérrez & Paul Brown. (2016) Rheumatoid arthritis prevalence in Colombia: An approach based on burden of disease study during 2005. Revista Colombiana de Reumatología (English Edition) 23:1, pages 11-16.
Crossref
Crossref
Jorge Augusto Díaz-Rojas, Fabián Antonio Dávila-Ramírez, Gerardo Quintana-López, Fabio Aristizábal-Gutiérrez & Paul Brown. (2016) Prevalencia de artritis reumatoide en Colombia: una aproximación basada en la carga de la enfermedad durante el año 2005. Revista Colombiana de Reumatología 23:1, pages 11-16.
Crossref
Crossref
Gerardo Antonio Muñetón & Gerardo Quintana. (2015) La epidemiología de la artritis reumatoide. Revista Colombiana de Reumatología 22:3, pages 145-147.
Crossref
Crossref
BURKHARD F. LEEB & HARSONO T.H. MAI. (2015) Smoking — Does It Affect Rheumatoid Arthritis Activity? Does It Matter?. The Journal of Rheumatology 42:7, pages 1072-1074.
Crossref
Crossref
Yasushi Inoue, Ayako Nakajima, Eiichi Tanaka, Eisuke Inoue, Akiko Kobayashi, Daisuke Hoshi, Naoki Sugimoto, Yohei Seto, Atsuo Taniguchi, Shigeki Momohara & Hisashi Yamanaka. (2015) Effect of Smoking on Remission Proportions Differs Between Male and Female Patients with Rheumatoid Arthritis: A Study Based on the IORRA Survey. The Journal of Rheumatology 42:7, pages 1083-1089.
Crossref
Crossref
Yutaka Ito, Toyohiro Hirai, Kohei Fujita, Koichi Maekawa, Akio Niimi, Satoshi Ichiyama & Michiaki Mishima. (2015) Increasing patients with pulmonary Mycobacterium avium complex disease and associated underlying diseases in Japan. Journal of Infection and Chemotherapy 21:5, pages 352-356.
Crossref
Crossref
Sachiko Nakaoka, Tatsuro Ishizaki, Hisashi Urushihara, Toshihiko Satoh, Shunya Ikeda, Mitsutoshi Yamamoto & Takeo Nakayama. (2014) Prescribing Pattern of Anti-Parkinson Drugs in Japan: A Trend Analysis from 2005 to 2010. PLoS ONE 9:6, pages e99021.
Crossref
Crossref
Takumi Matsumoto, Ichiro Nakamura, Ayumi Miura, Gen Momoyama & Katsumi Ito. (2014) Radiologic Patterning of Joint Damage to the Foot in Rheumatoid Arthritis. Arthritis Care & Research 66:4, pages 499-507.
Crossref
Crossref